Emergence of drug-resistant influenza virus: population dynamical considerations. (Q30353989)

20 June 2017

title

Emergence of drug-resistant influenza virus: population dynamical considerations. (English)

1 reference

20 June 2017

2

1 reference

20 June 2017

Roland R Regoes

1

1 reference

20 June 2017

language of work or name

English

0 references

publication date

1 April 2006

1 reference

20 June 2017

1 reference

20 June 2017

volume

312

1 reference

20 June 2017

issue

5772

1 reference

20 June 2017

page(s)

389-391

1 reference

Neuraminidase inhibitors for influenza

20 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.1122947

Perspectives on antiviral use during pandemic influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.1122947

Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.1122947

Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.1122947

Influenza virus neuraminidase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.1122947

Neuraminidase sequence analysis and susceptibilities of influenza virus clinical isolates to zanamivir and oseltamivir.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.1122947

Evidence for zanamivir resistance in an immunocompromised child infected with influenza B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.1122947

Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.1122947

Treatment of influenza with neuraminidase inhibitors: virological implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.1122947

Resistant influenza A viruses in children treated with oseltamivir: descriptive study

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.1122947

Biologic potential of amantadine-resistant influenza A virus in an avian model

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.1122947

Influenza virus carrying neuraminidase with reduced sensitivity to oseltamivir carboxylate has altered properties in vitro and is compromised for infectivity and replicative ability in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.1122947

Influenza virus carrying an R292K mutation in the neuraminidase gene is not transmitted in ferrets

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.1122947

The H274Y mutation in the influenza A/H1N1 neuraminidase active site following oseltamivir phosphate treatment leave virus severely compromised both in vitro and in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.1122947

A population-dynamic model for evaluating the potential spread of drug-resistant influenza virus infections during community-based use of antivirals.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.1122947

Neuraminidase inhibitor-resistant influenza viruses may differ substantially in fitness and transmissibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.1122947

Influenza viruses resistant to the antiviral drug oseltamivir: transmission studies in ferrets

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.1122947

Adamantane resistance among influenza A viruses isolated early during the 2005-2006 influenza season in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.1122947

Strategies for containing an emerging influenza pandemic in Southeast Asia

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.1122947

Transmissibility of 1918 pandemic influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.1122947

The role of evolution in the emergence of infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.1122947

Containing pandemic influenza at the source.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.1122947

Emergence of Drug Resistance during an Influenza Epidemic: Insights from a Mathematical Model

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.1122947

Resistance to anti-infective drugs and the threat to public health

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.1122947

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.1122947

High frequency of resistant viruses harboring different mutations in amantadine-treated children with influenza

21 January 2018

1 reference

https://api.crossref.org/works/10.1126/SCIENCE.1122947

21 January 2018

Identifiers

DOI

10.1126/SCIENCE.1122947

1 reference

20 June 2017

1 reference